About 1 result found for searched term "1646267-59-5" (0.137 seconds)
Cat.No. | Name | Target |
---|---|---|
M21323 | ACT-660602 | CXCR |
ACT-660602 is an oral chemokine receptor CXCR3 antagonist with an IC50 of 204 nM. It is being developed for use in autoimmune diseases. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.